{"transactions":[{"id":4624177,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-09-18T20:45:01.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":118476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":118476,"derivative":{"underlying":"Common Stock","underlying_shares":118476},"source":{"system":"sec-edgar","filing":"0001754154-26-000016","document":"form4a-09182026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000016/form4a-09182026_080953.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4624176,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:45:01.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":118476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":118476,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":118476},"source":{"system":"sec-edgar","filing":"0001754154-26-000016","document":"form4a-09182026_080953.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000016/form4a-09182026_080953.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4618677,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-09-15T23:07:20.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":118476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":118476,"derivative":{"underlying":"Common Stock","underlying_shares":118476},"source":{"system":"sec-edgar","filing":"0001754154-26-000014","document":"form4-09152026_110910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754154/000175415426000014/form4-09152026_110910.xml","form_type":"4"}},{"id":4618676,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-15T23:07:20.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":118476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":118476,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":118476},"source":{"system":"sec-edgar","filing":"0001754154-26-000014","document":"form4-09152026_110910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754154/000175415426000014/form4-09152026_110910.xml","form_type":"4"}},{"id":774806,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-18T20:04:39.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":38265,"price":3.92,"value":149998.8,"ownership":{"direct":true},"balance_after":333489,"source":{"system":"sec-edgar","filing":"0001754154-26-000012","document":"form4-05182026_080534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000012/form4-05182026_080534.xml","form_type":"4"}},{"id":805515,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-17T20:53:19.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":141600,"price":4.13,"value":584808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":295224,"source":{"system":"sec-edgar","filing":"0001754154-26-000010","document":"form4-04172026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000010/form4-04172026_080413.xml","form_type":"4"}},{"id":805514,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-17T20:53:19.000Z","date":"2026-04-15","kind":"sale","planned":false,"acquired":false,"shares":77000,"price":3.86,"value":297220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 11,822 shares of Common Stock acquired between November 14, 2022 and November 15, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":436824,"source":{"system":"sec-edgar","filing":"0001754154-26-000010","document":"form4-04172026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000010/form4-04172026_080413.xml","form_type":"4"}},{"id":816110,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-03T22:18:43.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":300677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2026."}],"balance_after":300677,"derivative":{"exercise_price":3.54,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":300677},"source":{"system":"sec-edgar","filing":"0001754154-26-000005","document":"form4-04032026_100439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000005/form4-04032026_100439.xml","form_type":"4"}},{"id":816109,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T22:18:43.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":473902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":473902},"source":{"system":"sec-edgar","filing":"0001754154-26-000005","document":"form4-04032026_100439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000005/form4-04032026_100439.xml","form_type":"4"}},{"id":816108,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T22:18:43.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":473902,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":502002,"source":{"system":"sec-edgar","filing":"0001754154-26-000005","document":"form4-04032026_100439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000005/form4-04032026_100439.xml","form_type":"4"}},{"id":850802,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T23:36:03.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":13500,"derivative":{"underlying":"Common Stock","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0001754154-26-000002","document":"form4-03102026_110300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000002/form4-03102026_110300.xml","form_type":"4"}},{"id":850801,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:36:03.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":2594,"price":3.3096,"value":8585.1024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":28100,"source":{"system":"sec-edgar","filing":"0001754154-26-000002","document":"form4-03102026_110300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000002/form4-03102026_110300.xml","form_type":"4"}},{"id":850800,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:36:03.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":6750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":30694,"source":{"system":"sec-edgar","filing":"0001754154-26-000002","document":"form4-03102026_110300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000175415426000002/form4-03102026_110300.xml","form_type":"4"}},{"id":1179313,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-03T23:23:48.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":473902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":473902,"derivative":{"underlying":"Common Stock","underlying_shares":473902},"source":{"system":"sec-edgar","filing":"0001415889-25-010079","document":"form4-04032025_110445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010079/form4-04032025_110445.xml","form_type":"4"}},{"id":1179312,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T23:23:48.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":473902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":473902,"derivative":{"exercise_price":1.7,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":473902},"source":{"system":"sec-edgar","filing":"0001415889-25-010079","document":"form4-04032025_110445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010079/form4-04032025_110445.xml","form_type":"4"}},{"id":1235601,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T01:38:40.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":20250,"derivative":{"underlying":"Common Stock","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0001415889-25-006318","document":"form4-03042025_010336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006318/form4-03042025_010336.xml","form_type":"4"}},{"id":1235600,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:38:40.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":2806,"price":2.35,"value":6594.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":23944,"source":{"system":"sec-edgar","filing":"0001415889-25-006318","document":"form4-03042025_010336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006318/form4-03042025_010336.xml","form_type":"4"}},{"id":1235599,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T01:38:40.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":6750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."}],"balance_after":26750,"source":{"system":"sec-edgar","filing":"0001415889-25-006318","document":"form4-03042025_010336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006318/form4-03042025_010336.xml","form_type":"4"}},{"id":1602813,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-05T00:12:30.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":27000,"derivative":{"underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001415889-24-006411","document":"form4-03052024_120310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006411/form4-03052024_120310.xml","form_type":"4"}},{"id":1602812,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T00:12:30.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":55000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001415889-24-006411","document":"form4-03052024_120310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006411/form4-03052024_120310.xml","form_type":"4"}},{"id":1602811,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T00:12:30.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":138263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date.  \"Grant Date\" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance."}],"balance_after":138263,"derivative":{"exercise_price":1.92,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":138263},"source":{"system":"sec-edgar","filing":"0001415889-24-006411","document":"form4-03052024_120310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588924006411/form4-03052024_120310.xml","form_type":"4"}},{"id":1927752,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Interim CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-04T20:07:39.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 3, 2023."}],"balance_after":100000,"derivative":{"exercise_price":7.47,"expiration_date":"2033-04-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-022657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919123022657/doc4.xml","form_type":"4"}},{"id":1979208,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-03-02T21:08:27.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2023."}],"balance_after":90000,"derivative":{"exercise_price":10.93,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-014603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919123014603/doc4.xml","form_type":"4"}},{"id":2150469,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-27T23:17:11.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":20000,"price":12.5,"value":250000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-22-051388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919122051388/doc4.xml","form_type":"4"}},{"id":2304093,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-04-06T00:17:07.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":46400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean April 1, 2022."}],"balance_after":46400,"derivative":{"exercise_price":17.24,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":46400},"source":{"system":"sec-edgar","filing":"0001209191-22-023350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000120919122023350/doc4.xml","form_type":"4"}},{"id":2722841,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":70092,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":70092},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722840,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":43824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":43824},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722839,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":86928,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":86928},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722838,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":144828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":144828},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722837,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":12576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":12576},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722836,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":83844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":83844},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722835,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":10404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":10404},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722834,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":8136,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":8136},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722833,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":44184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.3342,"expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":44184},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722832,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":68460,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":9.6092,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":68460},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722831,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":67164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":8.6433,"expiration_date":"2027-05-18","underlying":"Ordinary Shares","underlying_shares":67164},"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2722830,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T16:15:31.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":165108,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321018661/doc4.xml","form_type":"4"}},{"id":2808517,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-03-04T21:07:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":43824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":43824,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":43824},"source":{"system":"sec-edgar","filing":"0000899243-21-010024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321010024/doc4.xml","form_type":"4"}},{"id":2808516,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-03-04T21:07:31.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":70092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":70092,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":70092},"source":{"system":"sec-edgar","filing":"0000899243-21-010024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321010024/doc4.xml","form_type":"4"}},{"id":2819566,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:25:25.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-03-01","expiration_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":6288},"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819565,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":10404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":10404},"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819564,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":138756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":138756},"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819563,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":3300,"price":17.85,"value":58905.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":165108,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819562,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":6288,"price":0.0014,"value":8.8032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":168408,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819561,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":5447,"price":17.9,"value":97501.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":161120,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819560,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":10404,"price":0.0014,"value":14.5656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":167567,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819559,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":72649,"price":17.9,"value":1300417.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":157163,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2819558,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:25:25.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":138756,"price":0.0014,"value":194.2584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":229812,"source":{"system":"sec-edgar","filing":"0000899243-21-009212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321009212/doc4.xml","form_type":"4"}},{"id":2835507,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:45:18.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":70128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":70128,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":70128},"source":{"system":"sec-edgar","filing":"0000899243-21-008086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008086/doc4.xml","form_type":"4"}},{"id":2835506,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2021-02-24T18:45:18.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":43812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":43812,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":43812},"source":{"system":"sec-edgar","filing":"0000899243-21-008086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924321008086/doc4.xml","form_type":"4"}},{"id":3118522,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:04:43.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":86928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":86928,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":86928},"source":{"system":"sec-edgar","filing":"0000899243-20-015697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015697/doc4.xml","form_type":"4"}},{"id":3118521,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options","published_at":"2020-06-08T20:04:43.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":144828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."}],"balance_after":144828,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":144828},"source":{"system":"sec-edgar","filing":"0000899243-20-015697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320015697/doc4.xml","form_type":"4"}},{"id":3140650,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":8136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0012,"exercise_date":"2020-05-18","expiration_date":"2020-05-18","underlying":"Ordinary Shares","underlying_shares":8136},"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3140649,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":108468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0012,"exercise_date":"2020-05-18","expiration_date":"2020-05-18","underlying":"Ordinary Shares","underlying_shares":108468},"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3140648,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":4032,"price":9.67,"value":38989.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":91062,"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3140647,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":8136,"price":0.0012,"value":9.7632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."}],"balance_after":95094,"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3140646,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"tax_withholding","acquired":false,"shares":53784,"price":9.67,"value":520091.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":86958,"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3140645,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-20T20:01:01.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":108468,"price":0.0012,"value":130.1616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.22 U.S. Dollars as of May 18, 2020."}],"balance_after":140742,"source":{"system":"sec-edgar","filing":"0000899243-20-013766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/doc4.xml","form_type":"4"}},{"id":3204871,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-17T18:07:19.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":7200,"price":6.8,"value":48960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":88224,"source":{"system":"sec-edgar","filing":"0000899243-20-008656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320008656/doc4.xml","form_type":"4"}},{"id":3227364,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T18:00:34.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":2220,"price":8.34,"value":18514.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale to cover vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":81024,"source":{"system":"sec-edgar","filing":"0000899243-20-006992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006992/doc4.xml","form_type":"4"}},{"id":3241013,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T18:01:31.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":228,"price":9.17,"value":2090.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":83244,"source":{"system":"sec-edgar","filing":"0000899243-20-006327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006327/doc4.xml","form_type":"4"}},{"id":3241012,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T18:01:31.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":3624,"price":9.17,"value":33232.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":83472,"source":{"system":"sec-edgar","filing":"0000899243-20-006327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924320006327/doc4.xml","form_type":"4"}},{"id":3516762,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-18","kind":"exercise","acquired":false,"shares":8136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 8,136 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-05-18","expiration_date":"2019-05-18","underlying":"Ordinary Shares","underlying_shares":8136},"source":{"system":"sec-edgar","filing":"0000899243-19-014293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/doc4.xml","form_type":"4"}},{"id":3516761,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":4224,"price":14.52,"value":61332.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is price per ordinary share converted from price per ADS."}],"balance_after":87096,"source":{"system":"sec-edgar","filing":"0000899243-19-014293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/doc4.xml","form_type":"4"}},{"id":3516760,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-21T20:00:38.000Z","date":"2019-05-18","kind":"exercise","acquired":true,"shares":8136,"price":0.0013,"value":10.5768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares (\"ADS\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 47,496 and 25,152 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively."}],"balance_after":91320,"source":{"system":"sec-edgar","filing":"0000899243-19-014293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/doc4.xml","form_type":"4"}},{"id":3611678,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6288,"derivative":{"exercise_price":0.0013,"exercise_date":"2023-03-01","underlying":"Ordinary Shares","underlying_shares":6288},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3611677,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6288,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","underlying":"Ordinary Shares","underlying_shares":6288},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3611676,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6288,"derivative":{"exercise_price":0.0013,"exercise_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":6288},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3611675,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options will vest automatically on exercisable date."}],"balance_after":6288,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-03-01","underlying":"Ordinary Shares","underlying_shares":6288},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3611674,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":83844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019."}],"balance_after":83844,"derivative":{"exercise_price":0.0013,"exercise_date":"2022-03-01","expiration_date":"2023-03-15","underlying":"Ordinary Shares","underlying_shares":83844},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3611673,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-03-05T21:03:00.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":44184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The reported options are options to purchase American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price reported is price per ordinary share converted from price per ADS ($172.01)."}],"balance_after":44184,"derivative":{"exercise_price":14.33,"exercise_date":"2022-03-01","expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":44184},"source":{"system":"sec-edgar","filing":"0000899243-19-006326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319006326/doc4.xml","form_type":"4"}},{"id":3626035,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-02-28T17:00:54.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":10404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019."}],"balance_after":3,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-02-26","expiration_date":"2020-03-15","underlying":"Ordinary Shares","underlying_shares":10404},"source":{"system":"sec-edgar","filing":"0000899243-19-005257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005257/doc4.xml","form_type":"4"}},{"id":3626034,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:00:54.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":48,"price":12.38,"value":594.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":10536,"source":{"system":"sec-edgar","filing":"0000899243-19-005257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005257/doc4.xml","form_type":"4"}},{"id":3626033,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:00:54.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":3600,"price":12.46,"value":44856.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":10584,"source":{"system":"sec-edgar","filing":"0000899243-19-005257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005257/doc4.xml","form_type":"4"}},{"id":3626032,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:00:54.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":1584,"price":12.42,"value":19673.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These ordinary shares are represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":14184,"source":{"system":"sec-edgar","filing":"0000899243-19-005257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005257/doc4.xml","form_type":"4"}},{"id":3626031,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":46412,"kind":"person","name":"Giacobello Scott M.","position":1,"cik":"0001754154","reported_name":"Giacobello Scott M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-28T17:00:54.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":10404,"price":0.0013,"value":13.5252,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into 867 American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019."}],"balance_after":15768,"source":{"system":"sec-edgar","filing":"0000899243-19-005257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1351288/000089924319005257/doc4.xml","form_type":"4"}}]}